In the present study we synthesized new methoxy derivatives of trans 2,3-diaryl-2,3-dihydrobenzofurans, starting from suitable trans 2,3-diaryloxiranes, using regio- and stereoselective nucleophilic oxiranyl ring-opening reactions. The compounds were tested as anti-inflammatories in U937 cells. All compounds showed a significant role in inhibiting the NF-kappa B pathway and were able to restore normal ROS and NO level upon LPS activation. Moreover, regarding inhibition of ACLY, enantioenriched (50% ee) 7a(50) showed more potency than the racemic counterpart 7arac, together with a higher reduction of prostaglandin E-2 production, thus suggesting a stereoselective interaction in this pathway.
Synthesis of new methoxy derivatives of trans 2,3-diaryl-2,3-dihydrobenzofurans and evaluation of their anti-inflammatory activity / Laurita, T; Pappalardo, I; Chiummiento, L; D'Orsi, R; Funicello, M; Santarsiero, A; Marsico, M; Infantino, V; Todisco, S; Lupattelli, P. - In: BIOORGANIC & MEDICINAL CHEMISTRY LETTERS. - ISSN 0960-894X. - 49:(2021), pp. 1-7. [10.1016/j.bmcl.2021.128264]
Synthesis of new methoxy derivatives of trans 2,3-diaryl-2,3-dihydrobenzofurans and evaluation of their anti-inflammatory activity
Lupattelli, P
2021
Abstract
In the present study we synthesized new methoxy derivatives of trans 2,3-diaryl-2,3-dihydrobenzofurans, starting from suitable trans 2,3-diaryloxiranes, using regio- and stereoselective nucleophilic oxiranyl ring-opening reactions. The compounds were tested as anti-inflammatories in U937 cells. All compounds showed a significant role in inhibiting the NF-kappa B pathway and were able to restore normal ROS and NO level upon LPS activation. Moreover, regarding inhibition of ACLY, enantioenriched (50% ee) 7a(50) showed more potency than the racemic counterpart 7arac, together with a higher reduction of prostaglandin E-2 production, thus suggesting a stereoselective interaction in this pathway.File | Dimensione | Formato | |
---|---|---|---|
Laurita_Synthesis_2021.pdf
solo gestori archivio
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
1.58 MB
Formato
Adobe PDF
|
1.58 MB | Adobe PDF | Contatta l'autore |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.